Literature DB >> 11388376

Pharmacological analysis of the subunit composition of the AMPA receptor in hippocampal neurons.

K V Bolshakov1, S L Buldakova.   

Abstract

Experiments were performed on isolated neurons from hippocampal field CA1 and the dentate fascia to identify the subunit composition and distribution of splicing variants of AMPA receptor subunits. Currents evoked by the application of kainate were recorded using a whole-cell patch clamping method. The presence of GluR2 subunits in receptors was associated with a sharp reduction in the activity of the selective channel blocker IEM-1460. The composition of flip versions of subunits was assessed using cyclothiazide. AMPA receptors in the major cell types (pyramidal and granule cells) had low sensitivity to IEM-1460, while AMPA receptors of other cells (interneurons) had high or intermediate sensitivity. Cyclothiazide had strong potentiating effects on the main cell types in both structures as compared with interneurons. Thus, there is a correlation between the sensitivities of hippocampal neurons to IEM-1460 and cyclothiazide. The main cell types in both structures expressed large quantities of the GluR2 subunit in their AMPA receptors, with high levels of flip subunits, as compared with the other cell types, in which GluR2 subunits were virtually absent and the flop version predominated. This appears to reflect the functional features of different types of neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388376     DOI: 10.1023/a:1005276627192

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  37 in total

Review 1.  The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels.

Authors:  P H Seeburg
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

Review 2.  Anatomic organization and physiology of the limbic cortex.

Authors:  F H Lopes da Silva; M P Witter; P H Boeijinga; A H Lohman
Journal:  Physiol Rev       Date:  1990-04       Impact factor: 37.312

Review 3.  Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists.

Authors:  J C Watkins; P Krogsgaard-Larsen; T Honoré
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

4.  Expression of AMPA-glutamate receptor B subunit in rat hippocampal GABAergic neurons.

Authors:  C Racca; M V Catania; H Monyer; B Sakmann
Journal:  Eur J Neurosci       Date:  1996-08       Impact factor: 3.386

Review 5.  Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels.

Authors:  P Jonas; N Burnashev
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

6.  Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS.

Authors:  J R Geiger; T Melcher; D S Koh; B Sakmann; P H Seeburg; P Jonas; H Monyer
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

7.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.

Authors:  H Lomeli; J Mosbacher; T Melcher; T Höger; J R Geiger; T Kuner; H Monyer; M Higuchi; A Bach; P H Seeburg
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

8.  A family of AMPA-selective glutamate receptors.

Authors:  K Keinänen; W Wisden; B Sommer; P Werner; A Herb; T A Verdoorn; B Sakmann; P H Seeburg
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

9.  Calcium-permeable AMPA receptors mediate long-term potentiation in interneurons in the amygdala.

Authors:  N K Mahanty; P Sah
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

10.  Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes.

Authors:  N Burnashev; Z Zhou; E Neher; B Sakmann
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

View more
  1 in total

1.  AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.

Authors:  Nicole M Lykens; David J Coughlin; Jyoti M Reddi; Gordon J Lutz; Melanie K Tallent
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.